Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1670541/000167054120000061/adnt-20200630.htm
May 2023
May 2023
April 2023
March 2023
March 2023
February 2023
November 2022
November 2022
October 2022
September 2022
Three Months Ended June 30, | ||||||||||||||
(in millions, except per share data) | 2020 | 2019 | ||||||||||||
Net sales | $ | 1,626 | $ | 4,219 | ||||||||||
Cost of sales | 1,779 | 4,008 | ||||||||||||
Gross profit | (153) | 211 | ||||||||||||
Selling, general and administrative expenses | 115 | 165 | ||||||||||||
Restructuring and impairment costs | 49 | 15 | ||||||||||||
Equity income (loss) | 48 | 64 | ||||||||||||
Earnings (loss) before interest and income taxes | (269) | 95 | ||||||||||||
Net financing charges | 58 | 60 | ||||||||||||
Other pension expense (income) | (1) | 5 | ||||||||||||
Income (loss) before income taxes | (326) | 30 | ||||||||||||
Income tax provision (benefit) | 5 | 338 | ||||||||||||
Net income (loss) | (331) | (308) | ||||||||||||
Income attributable to noncontrolling interests | (6) | 13 | ||||||||||||
Net income (loss) attributable to Adient | $ | (325) | $ | (321) | ||||||||||
Diluted earnings (loss) per share | $ | (3.46) | $ | (3.43) | ||||||||||
Shares outstanding at period end | 93.9 | 93.6 | ||||||||||||
Diluted weighted average shares | 93.9 | 93.6 |
June 30, | September 30, | |||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Assets | ||||||||||||||
Cash and cash equivalents | $ | 1,032 | $ | 924 | ||||||||||
Accounts receivable - net | 1,161 | 1,905 | ||||||||||||
Inventories | 737 | 793 | ||||||||||||
Assets held for sale | 31 | — | ||||||||||||
Other current assets | 498 | 494 | ||||||||||||
Current assets | 3,459 | 4,116 | ||||||||||||
Property, plant and equipment - net | 1,592 | 1,671 | ||||||||||||
Goodwill | 2,039 | 2,150 | ||||||||||||
Other intangible assets - net | 350 | 405 | ||||||||||||
Investments in partially-owned affiliates | 1,090 | 1,399 | ||||||||||||
Assets held for sale | 165 | — | ||||||||||||
Other noncurrent assets | 924 | 601 | ||||||||||||
Total assets | $ | 9,619 | $ | 10,342 | ||||||||||
Liabilities and Shareholders' Equity | ||||||||||||||
Short-term debt | $ | 380 | $ | 30 | ||||||||||
Accounts payable and accrued expenses | 1,798 | 3,073 | ||||||||||||
Liabilities held for sale | 26 | — | ||||||||||||
Other current liabilities | 879 | 732 | ||||||||||||
Current liabilities | 3,083 | 3,835 | ||||||||||||
Long-term debt | 4,147 | 3,708 | ||||||||||||
Liabilities held for sale | 10 | — | ||||||||||||
Other noncurrent liabilities | 765 | 559 | ||||||||||||
Redeemable noncontrolling interests | 42 | 51 | ||||||||||||
Shareholders' equity attributable to Adient | 1,250 | 1,848 | ||||||||||||
Noncontrolling interests | 322 | 341 | ||||||||||||
Total liabilities and shareholders' equity | $ | 9,619 | $ | 10,342 |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Operating Activities | ||||||||||||||
Net income (loss) attributable to Adient | $ | (325) | $ | (321) | ||||||||||
Income attributable to noncontrolling interests | (6) | 13 | ||||||||||||
Net income (loss) | (331) | (308) | ||||||||||||
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | ||||||||||||||
Depreciation | 67 | 68 | ||||||||||||
Amortization of intangibles | 8 | 11 | ||||||||||||
Pension and postretirement benefit expense (benefit) | 2 | 7 | ||||||||||||
Pension and postretirement contributions, net | (3) | (4) | ||||||||||||
Equity in earnings of partially-owned affiliates, net of dividends received | 188 | 106 | ||||||||||||
Deferred income taxes | (18) | 264 | ||||||||||||
Non-cash restructuring and impairment charges | 27 | — | ||||||||||||
Impairment of nonconsolidated partially owned affiliate | 6 | — | ||||||||||||
Equity-based compensation | 7 | 8 | ||||||||||||
Other | 5 | 11 | ||||||||||||
Changes in assets and liabilities: | ||||||||||||||
Receivables | 198 | 129 | ||||||||||||
Inventories | 46 | 51 | ||||||||||||
Other assets | 39 | 43 | ||||||||||||
Restructuring reserves | (27) | (20) | ||||||||||||
Accounts payable and accrued liabilities | (669) | (134) | ||||||||||||
Accrued income taxes | — | 34 | ||||||||||||
Cash provided (used) by operating activities | (455) | 266 | ||||||||||||
Investing Activities | ||||||||||||||
Capital expenditures | (73) | (98) | ||||||||||||
Sale of property, plant and equipment | 1 | 7 | ||||||||||||
Changes in long-term investments | — | 3 | ||||||||||||
Cash provided (used) by investing activities | (72) | (88) | ||||||||||||
Financing Activities | ||||||||||||||
Increase (decrease) in short-term debt | (654) | (2) | ||||||||||||
Increase (decrease) in long-term debt | 600 | 1,600 | ||||||||||||
Repayment of long-term debt | (2) | (1,201) | ||||||||||||
Debt financing costs | (9) | (37) | ||||||||||||
Dividends paid to noncontrolling interests | (8) | (10) | ||||||||||||
Other | — | (1) | ||||||||||||
Cash provided (used) by financing activities | (73) | 349 | ||||||||||||
Effect of exchange rate changes on cash and cash equivalents | (8) | 7 | ||||||||||||
Increase (decrease) in cash and cash equivalents | (608) | 534 |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Net Sales | ||||||||||||||
Americas | $ | 593 | $ | 2,010 | ||||||||||
EMEA | 698 | 1,752 | ||||||||||||
Asia | 346 | 530 | ||||||||||||
Eliminations | (11) | (73) | ||||||||||||
Total net sales | $ | 1,626 | $ | 4,219 |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Adjusted EBITDA | ||||||||||||||
Americas | $ | (83) | $ | 69 | ||||||||||
EMEA | (94) | 53 | ||||||||||||
Asia | 71 | 110 | ||||||||||||
Corporate-related costs (1) | (16) | (27) | ||||||||||||
Restructuring and impairment costs (2) | (49) | (15) | ||||||||||||
Purchase accounting amortization (3) | (9) | (11) | ||||||||||||
Restructuring related charges (4) | (5) | (5) | ||||||||||||
Impairment of nonconsolidated partially owned affiliate (8) | (6) | — | ||||||||||||
Stock based compensation | (7) | (8) | ||||||||||||
Depreciation | (67) | (68) | ||||||||||||
Other items (5) | (4) | (3) | ||||||||||||
Earnings (loss) before interest and income taxes | (269) | 95 | ||||||||||||
Net financing charges | (58) | (60) | ||||||||||||
Other pension income (expense) | 1 | (5) | ||||||||||||
Income (loss) before income taxes | $ | (326) | $ | 30 |
Three Months Ended June 30, | ||||||||||||||
(in millions, except per share data) | 2020 | 2019 | ||||||||||||
Income available to shareholders | ||||||||||||||
Net income (loss) attributable to Adient | $ | (325) | $ | (321) | ||||||||||
Weighted average shares outstanding | ||||||||||||||
Basic weighted average shares outstanding | 93.9 | 93.6 | ||||||||||||
Effect of dilutive securities: | ||||||||||||||
Stock options, unvested restricted stock and unvested performance share awards | — | — | ||||||||||||
Diluted weighted average shares outstanding | 93.9 | 93.6 |
• | Adjusted EBIT is defined as income before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales. | ||||
• | Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and stock based compensation. Certain corporate-related costs are not allocated to the business segments in determining Adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales. | ||||
• | Adjusted net income attributable to Adient is defined as net income attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits. | ||||
• | Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes. | ||||
• | Adjusted earnings per share is defined as Adjusted net income attributable to Adient divided by diluted weighted average shares. | ||||
• | Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or one-time items impacting equity income. | ||||
• | Free cash flow is defined as cash from operating activities less capital expenditures. | ||||
• | Net debt is calculated as gross debt less cash and cash equivalents. | ||||
Three Months Ended June 30, | ||||||||||||||||||||||||||||||||||||||
2020 | 2019 | |||||||||||||||||||||||||||||||||||||
(in millions, except per share data) | GAAP Results | Adj. | Adjusted Results | GAAP Results | Adj. | Adjusted Results | ||||||||||||||||||||||||||||||||
Net sales | $ | 1,626 | $ | — | $ | 1,626 | $ | 4,219 | $ | — | $ | 4,219 | ||||||||||||||||||||||||||
Cost of sales (6) | 1,779 | (1) | 1,778 | 4,008 | (6) | 4,002 | ||||||||||||||||||||||||||||||||
Gross profit | (153) | 1 | (152) | 211 | 6 | 217 | ||||||||||||||||||||||||||||||||
Selling, general and administrative expenses (7) | 115 | (12) | 103 | 165 | (11) | 154 | ||||||||||||||||||||||||||||||||
Restructuring and impairment costs (2) | 49 | (49) | — | 15 | (15) | — | ||||||||||||||||||||||||||||||||
Equity income (loss) (8) | 48 | 11 | 59 | 64 | 2 | 66 | ||||||||||||||||||||||||||||||||
Earnings (loss) before interest and income taxes (EBIT) | (269) | 73 | (196) | 95 | 34 | 129 | ||||||||||||||||||||||||||||||||
Memo accounts: | ||||||||||||||||||||||||||||||||||||||
Depreciation | 67 | 68 | ||||||||||||||||||||||||||||||||||||
Equity based compensation | 7 | 8 | ||||||||||||||||||||||||||||||||||||
Adjusted EBITDA | $ | (122) | $ | 205 | ||||||||||||||||||||||||||||||||||
Net financing charges (12) | 58 | — | 58 | 60 | (13) | 47 | ||||||||||||||||||||||||||||||||
Other pension expense (income) (11) | (1) | (2) | (3) | 5 | (6) | (1) | ||||||||||||||||||||||||||||||||
Income (loss) before income taxes | (326) | 75 | (251) | 30 | 53 | 83 | ||||||||||||||||||||||||||||||||
Income tax provision (benefit) (9) | 5 | 9 | 14 | 338 | (306) | 32 | ||||||||||||||||||||||||||||||||
Net income (loss) attributable to Adient | (325) | 64 | (261) | (321) | 357 | 36 | ||||||||||||||||||||||||||||||||
Diluted earnings (loss) per share | (3.46) | 0.68 | (2.78) | (3.43) | 3.81 | 0.38 | ||||||||||||||||||||||||||||||||
Diluted weighted average shares | 93.9 | — | 93.9 | 93.6 | 0.4 | 94.0 |
Three months ended June 30, 2020 | ||||||||||||||||||||||||||||||||
Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
Net sales | $ | 593 | $ | 698 | $ | 346 | $ | (11) | $ | 1,626 | ||||||||||||||||||||||
Adjusted EBITDA | $ | (83) | $ | (94) | $ | 71 | $ | (16) | $ | (122) | ||||||||||||||||||||||
Adjusted EBITDA margin | (14.0) | % | (13.5) | % | 20.5 | % | N/A | (7.5) | % | |||||||||||||||||||||||
Three months ended June 30, 2019 | ||||||||||||||||||||||||||||||||
Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
Net sales | $ | 2,010 | $ | 1,752 | $ | 530 | $ | (73) | $ | 4,219 | ||||||||||||||||||||||
Adjusted EBITDA | $ | 69 | $ | 53 | $ | 110 | $ | (27) | $ | 205 | ||||||||||||||||||||||
Adjusted EBITDA margin | 3.4 | % | 3.0 | % | 20.8 | % | N/A | 4.9 | % | |||||||||||||||||||||||
Three Months Ended June 30, | ||||||||||||||||||||||||||||||||||||||
2020 | 2019 | |||||||||||||||||||||||||||||||||||||
(in millions, except effective tax rate) | Income (loss) before income taxes | Tax impact | Effective tax rate | Income (loss) before income taxes | Tax impact | Effective tax rate | ||||||||||||||||||||||||||||||||
As reported | $ | (326) | $ | 5 | (1.5)% | $ | 30 | $ | 338 | n/m | ||||||||||||||||||||||||||||
Adjustments | 75 | 9 | 12.0% | 53 | (306) | n/m | ||||||||||||||||||||||||||||||||
As adjusted | $ | (251) | $ | 14 | (5.6)% | $ | 83 | $ | 32 | 38.6% | ||||||||||||||||||||||||||||
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Net income (loss) attributable to Adient | $ | (325) | $ | (321) | ||||||||||
Restructuring and impairment costs | 49 | 15 | ||||||||||||
Purchase accounting amortization | 9 | 11 | ||||||||||||
Restructuring related charges | 5 | 5 | ||||||||||||
Impairment of nonconsolidated partially owned affiliate -YFAI | 6 | — | ||||||||||||
Pension mark-to-market and settlement loss(11) | 2 | 6 | ||||||||||||
Deferred financing fee charge (12) | — | 13 | ||||||||||||
Other items (5) | 4 | 3 | ||||||||||||
Impact of adjustments on noncontrolling interests (10) | (2) | (2) | ||||||||||||
Tax impact of above adjustments and other tax items (9) | (9) | 306 | ||||||||||||
Adjusted net income attributable to Adient | $ | (261) | $ | 36 |
Three Months Ended June 30, | ||||||||||||||
2020 | 2019 | |||||||||||||
Diluted earnings (loss) per share as reported | $ | (3.46) | $ | (3.43) | ||||||||||
Restructuring and impairment costs | 0.53 | 0.16 | ||||||||||||
Purchase accounting amortization | 0.10 | 0.12 | ||||||||||||
Restructuring related charges | 0.05 | 0.05 | ||||||||||||
Impairment of nonconsolidated partially owned affiliate -YFAI | 0.06 | — | ||||||||||||
Pension mark-to-market and settlement loss(11) | 0.02 | 0.06 | ||||||||||||
Deferred financing fee charge (12) | — | 0.14 | ||||||||||||
Other items (5) | 0.04 | 0.04 | ||||||||||||
Impact of adjustments on noncontrolling interests (10) | (0.02) | (0.02) | ||||||||||||
Tax impact of above adjustments and other tax items (9) | (0.10) | 3.26 | ||||||||||||
Adjusted net income attributable to Adient | $ | (2.78) | $ | 0.38 | ||||||||||
June 30, | September 30, | |||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Cash | $ | 1,032 | $ | 924 | ||||||||||
Total debt | 4,527 | 3,738 | ||||||||||||
Net debt | $ | 3,495 | $ | 2,814 | ||||||||||
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Operating cash flow | $ | (455) | $ | 266 | ||||||||||
Capital expenditures | (73) | $ | (98) | |||||||||||
Free cash flow | $ | (528) | $ | 168 |
FY20 | FY19 | |||||||||||||||||||||||||
(in millions) | Q3 | YTD | Q3 | YTD | ||||||||||||||||||||||
Adjusted EBITDA | $ | (122) | $ | 386 | $ | 205 | $ | 572 | ||||||||||||||||||
(+/-) Net equity in earnings | 184 | 74 | 103 | (16) | ||||||||||||||||||||||
(-) Restructuring (cash) | (29) | (70) | (23) | (112) | ||||||||||||||||||||||
(+/-) Net Customer Tooling | (12) | (15) | 13 | 43 | ||||||||||||||||||||||
(+/-) Past Due Receivables | 48 | 57 | (2) | — | ||||||||||||||||||||||
(+/-) Trade Working Capital (Net AR/AP + Inventory) | (531) | (441) | (3) | (76) | ||||||||||||||||||||||
(+/-) Accrued Compensation | 42 | (41) | 9 | 48 | ||||||||||||||||||||||
(-) Interest paid | (43) | (148) | (12) | (82) | ||||||||||||||||||||||
(+/-) Tax refund/taxes paid | (24) | (79) | (40) | (88) | ||||||||||||||||||||||
(+/-) Other | 32 | 5 | 16 | 17 | ||||||||||||||||||||||
Operating cash flow | (455) | (272) | 266 | 306 | ||||||||||||||||||||||
Capital expenditures | (73) | (258) | (98) | (350) | ||||||||||||||||||||||
Free cash flow | $ | (528) | $ | (530) | $ | 168 | $ | (44) |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Restructuring charges | $ | (22) | $ | (15) | ||||||||||
Futuris China intangible assets impairment | (27) | — | ||||||||||||
$ | (49) | $ | (15) |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Futuris integration | $ | — | $ | (1) | ||||||||||
Transaction costs | (4) | (2) | ||||||||||||
$ | (4) | $ | (3) |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Purchase accounting amortization | $ | — | $ | (2) | ||||||||||
Restructuring related charges | (1) | (3) | ||||||||||||
Futuris integration | — | (1) | ||||||||||||
$ | (1) | $ | (6) |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Purchase accounting amortization | $ | (8) | $ | (9) | ||||||||||
Transaction costs | (4) | (2) | ||||||||||||
$ | (12) | $ | (11) |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Impairment of nonconsolidated partially owned affiliate - YFAI | $ | 6 | $ | — | ||||||||||
Restructuring related charges | 4 | 2 | ||||||||||||
Purchase accounting amortization | 1 | — | ||||||||||||
$ | 11 | $ | 2 |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2020 | 2019 | ||||||||||||
Valuation allowances | $ | — | $ | (254) | ||||||||||
Benefits associated with restructuring and impairment charges | 7 | 3 | ||||||||||||
Tax rate change | — | (58) | ||||||||||||
Other reconciling items | 2 | 3 | ||||||||||||
$ | 9 | $ | (306) |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1670541/000167054120000061/adnt-20200630.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Adient Plc.
Adient Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Adient Plc provided additional information to their SEC Filing as exhibits
Ticker: ADNT
CIK: 1670541
Form Type: 10-Q Quarterly Report
Accession Number: 0001670541-20-000061
Submitted to the SEC: Thu Aug 06 2020 4:19:03 PM EST
Accepted by the SEC: Thu Aug 06 2020
Period: Tuesday, June 30, 2020
Industry: Motor Vehicle Parts And Accessories